Print

Certara Corporation Enhances SYBYL-X Drug Design and Discovery Software Suite  
8/6/2013 10:09:23 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announced the release of version 2.1 of its SYBYL®-X molecular modeling and simulation suite. SYBYL-X is a comprehensive suite of computer-aided design tools developed to expedite drug design and other molecular discovery projects, from high throughput screening to late lead optimization.

Help employers find you! Check out all the jobs and post your resume.

//-->